✦ LIBER ✦

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

✍ Scribed by Charles L. Vogel; Anne C. Bayley; Reginald J. Brooker; Peter P. Anthony; John L. Ziegler

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 648 KB
Volume: 39
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197705)39:5<1923::aid-cncr2820390502>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of thalidomide in patient

Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma

✍ Albert Y. Lin; Nathalie Brophy; George A. Fisher; Sam So; Christopher Biggs; Tor 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

✍ Eileen M. O'Reilly; Keith E. Stuart; Pedro M. Sanz-Altamira; Gary K. Schwartz; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Use of surveillance for hepatocellular c

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

✍ Jessica A. Davila; Robert O. Morgan; Peter A. Richardson; Xianglin L. Du; Kather 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants

A random phase II study of mitoxantrone

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study

✍ Geoffrey Falkson; Louise M. Ryan; Lewis A. Johnson; Ian W. Simson; Barend J. Coe 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 3 views

Thalidomide in the treatment of patients

Thalidomide in the treatment of patients with hepatocellular carcinoma : A Phase II trial

✍ Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Ajay K. Nooka; Isaac I. Schn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that pote

Report of a national conference on liver

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

✍ Elizabeth A. Pomfret; Kenneth Washburn; Christoph Wald; Michael A. Nalesnik; Dav 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

A national conference was held to better characterize the long-term outcomes of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) and to assess whether it is justified to continue the policy of assigning increased priority for candidates with early-stage HCC on the transpla